Gastric Hyperplasia and Increased Proliferative Responses of Lymphocytes in Mice Lacking the COOH-terminal Ankyrin Domain of NF-κB2
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
The nfkb2 gene encodes the p100 precursor which produces the p52 protein after proteolytic cleavage of its COOH-terminal domain. Although the p52 product can act as an alternative subunit of NF-κB, the p100 precursor is believed to function as an inhibitor of Rel/NF-κB activity by cytoplasmic retention of Rel/NF-κB complexes, like other members of the IκB family. However, the physiological relevance of the p100 precursor as an IκB molecule has not been understood. To assess the role of the precursor in vivo, we generated, by gene targeting, mice lacking p100 but still containing a functional p52 protein. Mice with a homozygous deletion of the COOH-terminal ankyrin repeats of NF-κB2 (p100−/−) had marked gastric hyperplasia, resulting in early postnatal death. p100−/− animals also presented histopathological alterations of hematopoietic tissues, enlarged lymph nodes, increased lymphocyte proliferation in response to several stimuli, and enhanced cytokine production in activated T cells. Dramatic induction of nuclear κB–binding activity composed of p52-containing complexes was found in all tissues examined and also in stimulated lymphocytes. Thus, the p100 precursor is essential for the proper regulation of p52-containing Rel/NF-κB complexes in various cell types and its absence cannot be efficiently compensated for by other IκB proteins.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Function and Activation of NF-kappaB in the Immune System
Baeuerle, P. A., & Henkel, T. (1994) · Annual Review of Immunology · doi:10.1146/annurev.iy.12.040194.001041 · Cited by 4,745
A heparin-binding growth factor secreted by macrophage-like cells that is related to EGF
Higashiyama, S., Abraham, J. A., Miller, J., Fiddes, J. C., & Klagsbrun, M. (1991) · Science · doi:10.1126/science.1840698 · Cited by 1,127 · cited 7×
“Upon ligand binding, phosphorylation of several proteins including autophosphorylation of EGFR initiates a number of intracellular responses, such as transient expression of the nuclear oncogene products c-myc and c-fos.”
BackgroundInfluential
Cited by
Missing Pieces in the NF-κB Puzzle
Ghosh, S., & Karin, M. (2002) · Cell · doi:10.1016/s0092-8674(02)00703-1 · Cited by 3,638
Regulation and Function of NF-κB Transcription Factors in the Immune System
Vallabhapurapu, S., & Karin, M. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132641 · Cited by 2,588
NF-κB in cancer: from innocent bystander to major culprit
Karin, M., Cao, Y., Greten, F. R., & Li, Z.-W. (2002) · Nature Reviews Cancer · doi:10.1038/nrc780 · Cited by 2,478
Control of oncogenesis and cancer therapy resistance by the transcription factor NF-κB
Baldwin, A. S. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11991 · Cited by 1,434
Activation by IKKα of a Second, Evolutionary Conserved, NF-κB Signaling Pathway
Senftleben, U., Cao, Y., Xiao, G., Greten, F. R., Krähn, G., Bonizzi, G., Chen, Y., Hu, Y., Fong, A., Sun, S.-C., et al. (2001) · Science · doi:10.1126/science.1062677 · Cited by 1,359
Non-canonical NF-κB signaling pathway
Sun, S.-C. (2011) · Cell Research · doi:10.1038/cr.2010.177 · Cited by 1,197
Aberrant rel/nfkb genes and activity in human cancer
Rayet, B., & Gélinas, C. (1999) · Oncogene · doi:10.1038/sj.onc.1203221 · Cited by 1,110
Promiscuous Mutations Activate the Noncanonical NF-κB Pathway in Multiple Myeloma
Keats, J. J., Fonseca, R., Chesi, M., Schop, R., Baker, A., Chng, W.-J., Van Wier, S., Tiedemann, R., Shi, C.-X., Sebag, M., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.07.003 · Cited by 983
“Conversely, transgenic mice expressing constitutively active isoforms of NFKB2, analogous to the ones identified in a variety of lymphoid malignancies (Neri et al., 1991), have an expansion of their B cell population (Ciana et al., 1997; Ishikawa et al., 1997).”
BackgroundThe IκB kinase (IKK) and NF-κB: key elements of proinflammatory signalling
Karin, M., & Delhase, M. (2000) · Seminars in Immunology · doi:10.1006/smim.2000.0210 · Cited by 955
NF-κB signaling pathways in mammalian and insect innate immunity
Silverman, N., & Maniatis, T. (2001) · Genes & Development · doi:10.1101/gad.909001 · Cited by 907
NF-κB-Inducing Kinase Regulates the Processing of NF-κB2 p100
Xiao, G., Harhaj, E. W., & Sun, S.-C. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00187-3 · Cited by 834
McKay, L. I., & Cidlowski, J. A. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.4.0375 · Cited by 805
“Knockouts of p100 (which express functional p52 but no inhibitory portion of the precursor) die in the early postnatal period from gastric hyperplasia and exhibit overactive immune responses such as lymphocyte overproliferation and increased cytokine production (102).”
BackgroundFunctions of NF-κB1 and NF-κB2 in immune cell biology
BEINKE, S., & LEY, S. C. (2004) · Biochemical Journal · doi:10.1042/bj20040544 · Cited by 610
Mutations in the NF-κB signaling pathway: implications for human disease
Courtois, G., & Gilmore, T. D. (2006) · Oncogene · doi:10.1038/sj.onc.1209939 · Cited by 525
NF-κB Family of Transcription Factors: Central Regulators of Innate and Adaptive Immune Functions
Caamaño, J., & Hunter, C. A. (2002) · Clinical Microbiology Reviews · doi:10.1128/cmr.15.3.414-429.2002 · Cited by 510
NF-κB and the Transcriptional Control of Inflammation
(2018) · International Review of Cell and Molecular Biology · doi:10.1016/bs.ircmb.2017.07.007 · Cited by 498
Cogswell, P. C., Guttridge, D. C., Funkhouser, W. K., & Baldwin, A. S. (2000) · Oncogene · doi:10.1038/sj.onc.1203412 · Cited by 452
CD40 regulates the processing of NF-kappaB2 p100 to p52
Coope, H. J. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf542 · Cited by 440
NF-κB as a primary regulator of the stress response
Mercurio, F., & Manning, A. M. (1999) · Oncogene · doi:10.1038/sj.onc.1203174 · Cited by 411
Aberrant NF-κB signaling in lymphoma: mechanisms, consequences, and therapeutic implications
Jost, P. J., & Ruland, J. (2007) · Blood · doi:10.1182/blood-2006-07-025809 · Cited by 408
Dejardin, E. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.08.007 · Cited by 344
Genetic approaches in mice to understand Rel/NF-κB and IκB function: transgenics and knockouts
Gerondakis, S., Grossmann, M., Nakamura, Y., Pohl, T., & Grumont, R. (1999) · Oncogene · doi:10.1038/sj.onc.1203236 · Cited by 329
The transcription factor NF-κB: control of oncogenesis and cancer therapy resistance
Mayo, M. W., & Baldwin, A. S. (2000) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(00)00002-0 · Cited by 324
The role of immunoglobulin translocations in the pathogenesis of B-cell malignancies
Willis, T. G., & Dyer, M. J. S. (2000) · Blood · doi:10.1182/blood.v96.3.808 · Cited by 323
NF-κB Signaling Regulates Physiological and Pathological Chondrogenesis
Jimi, E., Huang, F., & Nakatomi, C. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20246275 · Cited by 321
Gerondakis, S., Grumont, R., Gugasyan, R., Wong, L., Isomura, I., Ho, W., & Banerjee, A. (2006) · Oncogene · doi:10.1038/sj.onc.1209944 · Cited by 304
Modulation of NF-κB Activity by Exchange of Dimers
Saccani, S., Pantano, S., & Natoli, G. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00227-2 · Cited by 301
Xiao, G., Fong, A., & Sun, S.-C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m401428200 · Cited by 295
Xiao, G. (2001) · The EMBO Journal · doi:10.1093/emboj/20.23.6805 · Cited by 294
The IκB Function of NF-κB2 p100 Controls Stimulated Osteoclastogenesis
Novack, D. V., Yin, L., Hagen-Stapleton, A., Schreiber, R. D., Goeddel, D. V., Ross, F. P., & Teitelbaum, S. L. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030116 · Cited by 281
Dependence of Self-Tolerance on TRAF6-Directed Development of Thymic Stroma
Akiyama, T., Maeda, S., Yamane, S., Ogino, K., Kasai, M., Kajiura, F., Matsumoto, M., & Inoue, J.-I. (2005) · Science · doi:10.1126/science.1105677 · Cited by 270
Aberrant activation of the androgen receptor by NF-κB2/p52 in prostate cancer cells.
Nadiminty, N., Lou, W., Sun, M., Chen, J., Yue, J., Kung, H.-J., Evans, C. P., Zhou, Q., & Gao, A. C. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3703 · Cited by 113
Shen, C., Zhao, X.-L., Ju, W., Zou, X.-B., Huo, L.-R., Yan, W., Zou, J.-H., Yan, G.-D., Jenkins, E. C., Brown, W. T., et al. (2011) · Journal of Molecular Neuroscience · doi:10.1007/s12031-010-9463-5 · Cited by 18
“IKKα-activated p52/p100 (NF-κB2)-dependent pathway plays a role in the regulation of the cell cycle and cell proliferation (Schneider et al. 2006; Barré and Perkins 2007; Ishikawa et al. 1997).”
Background
Metadata
- Authors
- Ishikawa, H., Carrasco, D., Claudio, E., Ryseck, R.-P., & Bravo, R.
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 1997-10-06
- Volume
- 186
- Issue
- 7
- Pages
- 999-1014
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2046265685
- Cited by
- 176
- References
- 2
- FWCI
- 3.34
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.